Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Viatris Inc. - Common Stock (NQ:VTRS)

8.960 +0.190 (+2.17%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Viatris Inc. - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
17 18 Next >
Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Viatris Inc. (VTRS) Investors of Class Action and to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
7 Stocks That Are Long Overdue for a Relief Rally
Here are seven stocks with the catalysts and fundamentals to support a sustained relief rally in this environment. 
Via InvestorPlace
It's Cheap and Pays a Big Dividend, But Is Viatris Stock a Buy?
It looks more appealing in theory than it is in terms of its actual performance. 
Via The Motley Fool
VTRS EQUITY ALERT: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Viatris Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – VTRS
From Rosen Law Firm
Via Business Wire
Should You Trust Viatris’ 5% Yield?
Viatris pays a $0.12 per share quarterly dividend, which comes out to a 5.1% yield. Let’s see if it’s sustainable. 
Via Talk Markets
Viatris Eyes Midpoint Of FY23 Guidance Post Mixed Q1 Performance
Viatris Inc (NASDAQ: VTRS)  
Via Benzinga
3 High-Yield Dividend Stocks You Probably Didn't Know Warren Buffett Owns
Buffett has a few cards up his sleeve with these stocks. 
Via The Motley Fool
VTRS INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Viatris Inc. Investors with Substantial Losses Have Opportunity to Lead the Viatris Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
Viatris Faces Shareholder Class Action Lawsuit: Johnson Fistel Encourages Investors to Seek Compensation for Alleged Wrongdoings – VRTS
From Johnson Fistel, LLP
Via Business Wire
Tuesday Talk: The Sky's The Limit Or Not
The sky can never be the limit for the market, though it sometimes seems that way. The limit for the debt ceiling could prove to be a different matter for some. 
Via Talk Markets
A Preview Of Viatris's Earnings
Via Benzinga
Analyst Expectations for Viatris's Future
Via Benzinga
A Bearish Sign Appears On Viatris's Chart
Via Benzinga
S&P 500 Stocks: Carnival, AMD Are Big Winners Today
AMD kept rebounding as Carnival led S&P 500 stocks on cruise line optimism. 
Via Investor's Business Daily
Woodstock For Capitalists
Good Morning Everyone! Regional bank PacWest is up 34% in pre-market after being up 81% Friday. They slashed their dividend to conserve capital. With a 19% short interest on the stock, there is... 
Via Benzinga
Earnings Scheduled For May 8, 2023
Companies Reporting Before The Bell • HNI (NYSE:HNI) is likely to report quarterly loss at $0.03 per share on revenue of $462.26 million. 
Via Benzinga
Overview Of Value Stocks In The Healthcare Sector
Via Benzinga
Want to Collect $1,100 in Dividends? Invest $20,000 in These 2 Stocks
There's a bit of risk with these stocks, but they should prove reliable in generating high dividend payments for your portfolio. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2023
Via Benzinga
Wall Street Thinks These 2 Value Stocks Could Soar
These two companies could produce significant upside for shareholders in the next 12 months. 
Via The Motley Fool
1 "Safe" Stock to Avoid and 1 to Consider Buying in April
There's more to the concept of safety than having a business model that looks safe. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For April 24, 2023
Via Benzinga
Here's How You Can Collect $100 in Dividends Every Month
These dividend stocks can be excellent sources of recurring cash flow for years. 
Via The Motley Fool
The Byzantine Adderall Shortage Puts Teva And Others In The Hot Seat
Millions of people are scrambling to get their ADHD medication. Here's why. 
Via Investor's Business Daily
The 7 Most Undervalued Nasdaq Stocks to Buy in April 2023
Each of these seven undervalued Nasdaq stocks have catalysts in play that could help bridge their respective valuation gaps. 
Via InvestorPlace
Which Is the Better Dividend Stock: Viatris or Apple?
One has a higher dividend yield, but there's more to the story. 
Via The Motley Fool
Coinbase Says US 1M Tech Jobs At Risk, Microsoft To Place Ads In ChatGPT Powered Bing Search, Netflix Preps For Big Transition Into TV Gaming: Today's Top Stories
Benzinga 
Via Benzinga
Viatris Among Three Companies Licensed To Make GSK/Pfizer-Backed Long Acting HIV Prevention Drug
Via Benzinga
Don't Be Fooled by These 3 Value Traps
Approximately one out of every ten U.S. listed stocks have a positive P/E ratio less than 10. Some are justifiably cheap; others are merely fool’s gold. 
Via MarketBeat
3 Healthcare Spinoffs Worth a Look, But 1 Has the Best Long-Term Potential
These three spinoffs are already profitable. 
Via The Motley Fool
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.